Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORASURE TECHNOLOGIES, INC.

(OSUR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

U.S. Omicron plan: boosters, free at-home tests, tighter travel rules

12/02/2021 | 11:50am EST

WASHINGTON, Dec 2 (Reuters) - The Biden administration is seeking to ramp up its pandemic response amid the official arrival of the Omicron coronavirus variant, laying out a plan on Thursday to make at-home COVID-19 tests available free of charge, accelerate its push for booster shots and tightening rules for travelers.

Below are some of the key measures in the plan, which U.S. President Joe Biden will address later on Thursday:

FREE AT-HOME, OVER-THE-COUNTER TESTS

Private health insurance companies will be required to reimburse customers for the cost of over-the-counter at-home COVID-19 tests, the White House said, with the administration issuing federal guidance by Jan. 15.

For the uninsured, at-home tests will be made available at no charge at community testing sites, it added.

At-home tests approved by the U.S. Food and Drug Administration include Abbott Laboratories' BinaxNOW, OraSure Technologies Inc's InteliSwab, ACON Laboratories' FlowFlex and Ellume's home test, among others.

WIDER PUSH FOR BOOSTER SHOTS

The U.S. Department of Health and Human Services along with pharmacy companies will launch a public information campaign to encourage booster shots, following the Centers for Disease Control and Prevention's (CDC) revised guidance this week recommending all adults get a booster.

Pharmacies will take additional steps to increase vaccine availability, including weekend and evening hours, according to the White House.

The Medicare insurance program for those over 65 and the disabled and the Medicaid program for low-income people will also make outreach efforts to encourage shots.

TIGHTER TRAVEL REQUIREMENTS

The U.S. CDC plans to require inbound international passengers be tested for COVID-19 within one day of departure, regardless of their vaccination status, sources separately told Reuters. Mask requirements on airplanes, trains and public transportation vehicles also will continue through March 18.

The new one-day testing requirement would apply to U.S. citizens as well as foreign nationals and could take effect as early as next week.

CDC officials also have ordered airlines to disclose passenger names and other information for those who have recently been in eight southern African countries that identified early Omicron cases and will give it to local and state public health agencies, according to documents seen by Reuters.

MORE FAMILY VACCINATION CLINICS

The administration plans to launch hundreds of family vaccination clinics nationwide that will allow eligible parents, grandparents and children to get initial vaccines and booster shots with a "one-stop-shop," the White House said.

Community health centers will host the clinics throughout December. Mobile health clinics will also be deployed across the country, starting in Washington and New Mexico, according to the plan. Retail pharmacies, including CVS Health Corp and Rite Aid Corp will also start allowing family-based appointment scheduling, the White House added.

INCREASING TREATMENT SUPPLIES

Biden will announce plans to ensure any new COVID-19 treatment pills approved by U.S. regulators will be "equitably accessible to all Americans, regardless of their income or their zip code," the White House said.

The administration is also working to secure 13 million doses of antiviral courses, it added. (Reporting by Susan Heavey Editing by Bill Berkrot)


© Reuters 2021
All news about ORASURE TECHNOLOGIES, INC.
01/13OraSure Says InteliSwab COVID-19 Rapid Tests Detect Omicron as Effectively as They Dete..
MT
01/13InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
AQ
01/11Eurobio Scientific Launches the Exclusive Distribution of the First Saliva Self-Test fo..
CI
01/11Review of COVID-19 tests remains top priority -acting U.S. FDA chief
RE
01/10ORASURE TECHNOLOGIES INC : Change in Directors or Principal Officers (form 8-K)
AQ
01/06ORASURE TECHNOLOGIES INC : Change in Directors or Principal Officers, Financial Statements..
AQ
01/05OraSure Technologies Expects Q4 Revenue of $60 Million; CEO to Leave at End of March
MT
01/05OraSure Announces Evaluation of Strategic Alternatives
CI
01/05OraSure Technologies Announces Actions to Enhance Stockholder Value
AQ
01/05OraSure Technologies, Inc. Announces Resignation of Stephen Tang as President, Effectiv..
CI
More news
Analyst Recommendations on ORASURE TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2021 232 M - -
Net income 2021 -23,5 M - -
Net cash 2021 209 M - -
P/E ratio 2021 -26,8x
Yield 2021 -
Capitalization 635 M 635 M -
EV / Sales 2021 1,83x
EV / Sales 2022 1,29x
Nbr of Employees 570
Free-Float -
Chart ORASURE TECHNOLOGIES, INC.
Duration : Period :
OraSure Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ORASURE TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 8,81 $
Average target price 12,80 $
Spread / Average Target 45,3%
EPS Revisions
Managers and Directors
Stephen S. Tang President, Chief Executive Officer & Director
Scott K. Gleason CFO, SVP-Investor Relations & Communications
Michael Celano Chairman
James Ted Rauth Senior Vice President-Operations
Agnieszka Gallagher Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ORASURE TECHNOLOGIES, INC.1.38%635
ABBOTT LABORATORIES-10.59%215 794
MEDTRONIC PLC2.57%141 985
BECTON, DICKINSON AND COMPANY5.23%75 431
HOYA CORPORATION-11.34%49 186
BAXTER INTERNATIONAL INC.0.51%43 200